Narcotic (Opioid) Analgesics Flashcards

1
Q

Opioid analgesia plays on endogeneous mechanisms to:

A
  • Inhibit the propagation of pain signals
  • Alter the emotional perception of pain
  • Elevate the pain threshold
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sites of opioid receptors regulating pain include:

A
  • Peripheral nociceptive terminals (peripheral analgesia)
  • The spine (spinal analgesia)
  • The brain (supraspinal analgesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three major opioid receptor types?

A
  • μ (Mu)
  • δ (Delta)
  • κ (Kappa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What can you say about the functional effects of the three receptors?

A

μ (Mu) receptor exerts most of the functional effects, with the exception of dysphoria, which is exerted by the κ (Kappa) receptor.

μ (Mu) receptor has the strongest effect on euphoria, κ (Kappa) receptor does not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the dosing features of narcotic analgesics?

A
  • Elderly patients usually require a lower dose to achieve effective pain relief than younger patients.
  • Neuropathic pain usually requires higher opioid doses than nociceptive pain.
  • Lower doses are usually required for continuous maintenance of pain relief than administration in response to recurrence of pain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dosing to effect of narcotic analgesics

A
  • Opioid analgesics should be started at a low dose, and carefully titrated until an adequate level of analgesia is obtained, or until adverse effects occur.
  • Failure of at least partial analgesia with incremental dosing may indicate unresponsiveness to therapy.
  • Opioids do not exert an appreciable analgesic effect until MEC is reached for some patients with chronic pain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical uses of opioid agonists?

A
  1. Analgesia: codeine, morphine, pethidine
  2. Anaesthetic adjuvant: fentanyl
  3. Cough suppressant/antitussive: codeine
  4. Anti-diarrhoeal: diphenoxylate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Characteristics of morphine

A
  • Strong μ agonist (weaker δ and κ agonist).
  • High maximum analgesic efficacy.
  • High liability for addiction/abuse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of methadone and fentanyl?

A
  • Strong μ agonists (no significant δ and κ affinity).
  • High maximum analgesic efficacy.
  • High liability for addiction/abuse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amongst methadone, morphine and fentanyl, which are long-acting and which are short-acting drugs?

A

Methadone: long-acting
Fentanyl: short-acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pethidine characteristics

A
  • Strong μ agonist (probably weaker δand κagonist).
  • Shorter duration of action than morphine (especially in neonate therefore used in labour) –> used as an epidural in labor.
  • N-demethylated in the liver to norpethidine (hallucinogenic and convulsant effects at high dose)–> hallucination and epilepsy can be potential side effects.
  • Restlessness rather than sedation
  • Antimuscarinic (i.e. parasympatholytic) therefore dry mouth, blurring of vision but no miosis and less spasm of smooth muscle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Codeine / Dihydrocodeine characteristics

A
  • Weak μ and δ agonist (probably not a κ agonist).
  • Low maximum analgesic efficacy.
  • Moderate liability for addiction/abuse.
  • ~10 % converted to morphine / dihydromorphine.
  • ~10 % of population show reduced analgesic effect due to lack of demethylating enzyme.
  • codeine is demethylated to become morphine which has much higher efficacy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tramadol characteristics

A
  • Weak μ agonist.

- Weak inhibitor of 5-HT and noradrenaline re-uptake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the relationship between ondansetron and tramadol?

A
  • Ondansetron has 5-HT3 antagonist activity, binds to the 5-HT3 receptors and blocks it.
  • Ondansetron + tramadol –> effect of analgesic activity on tramadol is reduced. Therefore tramadol may be a 5-HT3 agonist.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

respiratory depression: where does it occur, when is it lethal, which group of people should avoid taking opioids?

A
  • Actions in the nucleus tractus solitarius and nucleus ambiguus.
    » Reduce responses to CO2 and H+.
    » Suppress voluntary breathing.
- Becomes lethal in: 
>> overdose 
>> respiratory disease 
>> hepatic dysfunction 
>> combination with other CNS depressants 
>> young children 
- Opioids should be avoided in infants.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common adverse effects of opioid analgesics?

A
  • Respiratory depression
  • Nausea/vomiting (due to actions on the chemoreceptor trigger zone).
  • Drowsiness
  • Constipation (especially with chronic use)
  • Miosis
  • Pinpoint pupil
  • Mydriasis (following hypoxia)
  • Urinary retention
  • Postural hypotension and bradycardia
  • Immunosuppressant effect with long-term use
17
Q

Histamine release effects from morphine can cause:

A
  • Urticaria and itching
  • Bronchoconstriction
  • Hypotension due to vasodilatation
18
Q

Tolerance to opioid analgesics

A
  • Less effective after prolonged use

- Dose escalation required

19
Q

Physical dependence to opioid analgesics

A
  • Physiological dependence such that stopping the drug leads to physical withdrawal symptoms.
20
Q

Addiction to opioid analgesics

A
  • Psychological craving
  • Compulsive use
  • Loss of control over use
21
Q

_______ and _______ can lead to risk of overdose.

A

addiction, tolerance

22
Q

Discuss the uses of opioid antagonists (e.g. naloxone/naltrexone/nalmefene)

A
  • Strong μ antagonism, also δ and κ antagonism.
  • Naloxone is short-acting (usually intravenous).
  • Naltrexone is long-acting (oral administration).
  • Nalmefene is long-acting (intravenous).
  • Used to counteract opioid dose.
  • To be used with extreme caution in patients with opiate dependency as they can precipitate potentially fatal withdrawal syndrome.